Anti-inflammatory and Renoprotective Effect of Pretreatment Loading Dose Atorvastatin in CABG
Phase of Trial: Phase II
Latest Information Update: 24 Feb 2016
At a glance
- Drugs Atorvastatin (Primary)
- Indications Coronary artery disease
- Focus Biomarker; Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jun 2013 Actual initiation date changed from 1 Mar 2012 to April 2012 as reported by ClinicalTrials.gov.